CaĆete, Alex D.
HRN: 25-85-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/11/2024
09/25/2024
IVT
4.5g
Q8
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes